Final results from GCIG/ENGOT/AGO-OVAR 12, a randomised placebo-controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer

Caterina Ricci, Isabelle Ray-Coquard, David Cibula, Mansoor R. Mirza, Alexander Reuss, Nicoletta Colombo, Horst Koch, Frédéric Goffin, Antonio González-Martin, Petronella B. Ottevanger, Klaus Baumann, Line Bjørge, Anne Lesoin, Alexander Burges, Per Rosenberg, Martina Gropp-Meier, Maija Harrela, Philipp Harter, Jean-Sébastien Frenel, Tomas MinarikCarmela Pisano, Annette Hasenburg, Michael Merger, Andreas Du Bois

Risultato della ricerca: Contributo in rivistaArticolo in rivista

9 Citazioni (Scopus)

Fingerprint

Entra nei temi di ricerca di 'Final results from GCIG/ENGOT/AGO-OVAR 12, a randomised placebo-controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer'. Insieme formano una fingerprint unica.

Medicine & Life Sciences